I-Mab Biopharma collaborates with Roche for combination therapy
Clinical Research | News | 0 Comment | 11 Apr, 2019
I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of potential ...Read more
George Clinical establishes new presence in Singapore
Clinical Research | News | 0 Comment | 10 Apr, 2019
George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in ...Read more
NIH begins first-in-human trial of a universal influenza vaccine candidate
Clinical Research | News | 0 Comment | 05 Apr, 2019
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety ...Read more
Veeda Clinical Research Achieves ISO 27001:2013 Certification
Clinical Research | News | 0 Comment | 03 Apr, 2019
India's leading independent CRO, Veeda Clinical Research Pvt. Ltd. has announced that Bureau Veritas has award...Read more
Veeda Clinical Research successfully completes third inspection by NPRA
Clinical Research | News | 0 Comment | 27 Mar, 2019
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmedabad) and B...Read more
Eisai starts Phase III clinical trial for Alzheimer's drug
Clinical Research | News | 0 Comment | 25 Mar, 2019
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...Read more
WCG introduces a transformational solution for clinical research sites
Clinical Research | News | 0 Comment | 20 Mar, 2019
WIRB-Copernicus Group has introduced WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and ...Read more
Clinical Research | News | 0 Comment | 18 Mar, 2019
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the Nationa...Read more
Clinical Research | News | 0 Comment | 15 Mar, 2019
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinic...Read more
Alvotech enrolls first patient for Ph III study involving Biosimilar version of HUMIRA
Clinical Research | News | 0 Comment | 14 Mar, 2019
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical...Read more
Kezar Life Sciences to test a new drug formulation of KZR-616
Clinical Research | News | 0 Comment | 07 Mar, 2019
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing n...Read more
Dr Albers receives the distinguished Clinical Research Achievement Award for stroke research
Clinical Research | News | 0 Comment | 07 Mar, 2019
iSchemaView, the worldwide leader in advanced imaging for stroke care and research, is proud to announce that iSchemaVie...Read more
Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial
Clinical Research | News | 0 Comment | 25 Feb, 2019
Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drug...Read more
Foresee Pharma announces topline results of FP-001 LMIS in prostate cancer
Clinical Research | News | 0 Comment | 22 Feb, 2019
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced tha...Read more
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study
Clinical Research | News | 0 Comment | 22 Feb, 2019
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...Read more
Owlstone Medical partners with Shanghai Renji Hospital
Clinical Research | News | 0 Comment | 25 Feb, 2019
Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precis...Read more
Sosei Heptares initiates new clinical development programme
Clinical Research | News | 0 Comment | 22 Feb, 2019
Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030...Read more
Mallinckrodt presents analysis results for Therakos against aGvHD
Clinical Research | News | 0 Comment | 21 Feb, 2019
Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its compan...Read more